EUVIMEDEUVIMED entdecken
Open Access

Tumor microenvironment contribution to checkpoint blockade therapy. Lessons learned from Hodgkin lymphoma

Antonino Carbone iD, Annunziata Gloghini iD, Carmelo Carlo-Stella iD

Blood · 2023

DOI: 10.1182/blood.2022016590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood, 2023. Verfasst von Antonino Carbone und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Centro di Riferimento Oncologico Aviano, Istituto Nazionale Tumori, IRCCS, Aviano, Italy. Hauptthemen laut MEDLINE: Hodgkin Disease, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular, Mediastinal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Classic Hodgkin lymphoma (cHL) is characterized by a tumor microenvironment (TME) containing inflammatory/immune cells. Follicular lymphoma, mediastinal grey zone lymphoma and diffuse large B-cell lymphomas, may show a TME containing inflammatory/immune cells, but the TMEs are quite different. In these B-cell lymphomas and cHL, PD-1/PD-L1 blockade drugs differ in their effectiveness in patients with refractory/relapsed disease. Research should still explore innovative assays that could reveal which molecules are influencing the sensitivity or the resistance to therapy in an individual patient.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hodgkin DiseaseLymphoma, Large B-Cell, DiffuseLymphoma, FollicularMediastinal NeoplasmsHumansTumor Microenvironment

Autor:innen und Institutionen

  • Department of Pathology, Centro di Riferimento Oncologico Aviano, Istituto Nazionale Tumori, IRCCS, Aviano, Italy.
  • Department of Diagnostic Pathology and Laboratory Medicine, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Rozzano, Milan, Italy.
  • Department of Oncology and Hematology, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.

ORCID-Profile: Antonino Carbone, Annunziata Gloghini, Carmelo Carlo-Stella

Zitieren

APA

Carbone, A., Gloghini, A., & Carlo-Stella, C. (2023). Tumor microenvironment contribution to checkpoint blockade therapy. Lessons learned from Hodgkin lymphoma. Blood. https://doi.org/10.1182/blood.2022016590

Vancouver

Carbone A, Gloghini A, Carlo-Stella C. Tumor microenvironment contribution to checkpoint blockade therapy. Lessons learned from Hodgkin lymphoma. Blood. 2023. doi:10.1182/blood.2022016590

BibTeX
@article{Carbone2023,
  author = {Carbone, Antonino and Gloghini, Annunziata and Carlo-Stella, Carmelo},
  title = {Tumor microenvironment contribution to checkpoint blockade therapy. Lessons learned from Hodgkin lymphoma},
  journal = {Blood},
  year = {2023},
  doi = {10.1182/blood.2022016590}
}
Kostenlos starten →